Aspira Women's Health Inc.
AWH
$0.185
-$0.0018-0.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.96M | 8.92M | 8.99M | 9.15M | 9.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.96M | 8.92M | 8.99M | 9.15M | 9.18M |
| Cost of Revenue | 3.75M | 3.76M | 3.70M | 3.89M | 3.89M |
| Gross Profit | 5.21M | 5.16M | 5.29M | 5.26M | 5.28M |
| SG&A Expenses | 18.47M | 18.72M | 19.04M | 20.21M | 21.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.95M | 26.28M | 26.27M | 28.01M | 28.99M |
| Operating Income | -16.98M | -17.35M | -17.28M | -18.85M | -19.81M |
| Income Before Tax | -14.80M | -15.95M | -14.74M | -16.69M | -18.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.80 | -15.95 | -14.74 | -16.69 | -18.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.80M | -15.95M | -14.74M | -16.69M | -18.19M |
| EBIT | -16.98M | -17.35M | -17.28M | -18.85M | -19.81M |
| EBITDA | -16.87M | -17.22M | -17.12M | -18.65M | -19.58M |
| EPS Basic | -1.20 | -1.45 | -1.44 | -1.85 | -2.10 |
| Normalized Basic EPS | -0.79 | -0.94 | -1.01 | -1.26 | -1.39 |
| EPS Diluted | -1.20 | -1.45 | -1.44 | -1.85 | -2.10 |
| Normalized Diluted EPS | -0.79 | -0.94 | -1.01 | -1.26 | -1.39 |
| Average Basic Shares Outstanding | 50.18M | 44.55M | 40.43M | 36.90M | 34.79M |
| Average Diluted Shares Outstanding | 50.18M | 44.55M | 40.43M | 36.90M | 34.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
